Egerton Capital (UK) LLP: CRH PLC (CRH) (CRH): Quarterly 13F Position History
As of Q3 2026, Egerton Capital (UK) LLP reported 3,631,232 shares of CRH PLC (CRH) (CRH), worth $300.7M and representing 3.1% of its 13F equity book. Quarter-over-quarter share count change: 752,634 (-17.2%) . The position first appeared in Q4 2023 and has been disclosed across 12 13F-HR filings in Pactolio's tracked window.
- 3,631,232Shares Held (Latest Filing)
- $300.7MReported Market Value (Latest Filing)
- 3.1%Portfolio Weight (% of 13F Equity Book)
- 752,634Quarter-over-Quarter Share Change
- -$168.4MQuarter-over-Quarter Value Change
- 4,570,564Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 12 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q3 2026 | 3,631,232 | 752,634 | -17.2% | $300.7M | 3.1% | $82.8 |
| Q2 2026 | 4,383,866 | +1,624,535 | +58.9% | $469.1M | 4.5% | $107.0 |
| Q1 2026 | 2,759,331 | +498,271 | +22.0% | $290.1M | 3.2% | $105.1 |
| Q4 2025 | 2,261,060 | 1,999,786 | -46.9% | $282.2M | 3.1% | $124.8 |
| Q3 2025 | 4,260,846 | 309,718 | -6.8% | $510.9M | 5.4% | $119.9 |
| Q2 2025 | 4,570,564 | +339,328 | +8.0% | $419.6M | 4.3% | $91.8 |
| Q1 2025 | 4,231,236 | 97,656 | -2.3% | $372.2M | 4.3% | $88.0 |
| Q4 2024 | 4,328,892 | 86,766 | -2.0% | $400.5M | 4.6% | $92.5 |
| Q3 2024 | 4,415,658 | +475,305 | +12.1% | $409.5M | 4.1% | $92.7 |
| Q2 2024 | 3,940,353 | 295,084 | -7.0% | $295.4M | 3.0% | $75.0 |
| Q1 2024 | 4,235,437 | +842,172 | +24.8% | $365.3M | 3.5% | $86.3 |
| Q4 2023 | 3,393,265 | – | – | $234.7M | 2.5% | $69.2 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Egerton Capital (UK) LLP first disclose a CRH position in 13F-HR filings?
Egerton Capital (UK) LLP first reported CRH PLC (CRH) (CRH) on its 13F-HR filing for the period ending 2023-12-31 (Q4 2023). The position has appeared on 12 reported quarters within Pactolio's tracked window.
What was Egerton Capital (UK) LLP's most recent quarter-over-quarter share-count change in CRH?
Between Q2 2026 and Q3 2026, Egerton Capital (UK) LLP reduced its CRH position by 752,634 shares (-17.2%), leaving 3,631,232 shares at a market value of $300.7M.
Does the implied price-per-share represent Egerton Capital (UK) LLP's cost basis in CRH?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.